Browse the complete record of transactions filed by JEFFS ROGER, Chief Executive Officer. Director active across 2 companies, notably Liquidia Corp. Aggregated, 12 filings have been published. Total volume traded: €4.5m. The latest transaction was filed on 13 May 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Roger Jeffs is the Chief Executive Officer of Liquidia Corp and Axsome Therapeutics, Inc. With significant experience in the biopharmaceutical sector, he leads strategic initiatives to promote innovation and growth within these companies. His vision and leadership are essential for navigating a complex and ever-evolving environment.